Active, not recruitingPhase 2NCT00110110
Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma
Studying Hereditary retinoblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Hospital for Sick Children
- Principal Investigator
- Brenda L Gallie, MDThe Hospital for Sick Children
- Intervention
- filgrastim(biological)
- Enrollment
- 71 enrolled
- Eligibility
- All sexes
- Timeline
- 2004 – 2024
Study locations (6)
- Children's and Women's Hospital of British Columbia, Vancouver, British Columbia, Canada
- Hospital for Sick Children, Toronto, Ontario, Canada
- Montreal Children's Hospital at McGill University Health Center, Montreal, Quebec, Canada
- Hospital San Juan de Dios, Santiago, Chile
- Sankara Nethralaya Super Specialty Clinic, Chennai, India
- Kandang Kerbau Women's and Children's Hospital, Singapore, Singapore
Collaborators
Terry Fox Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00110110 on ClinicalTrials.govOther trials for Hereditary retinoblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06725173Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.University of Washington
- RECRUITINGEARLY PHASE1NCT06972602High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous SeedEye & ENT Hospital of Fudan University
- RECRUITINGPHASE2NCT06679634Retinoblastoma Phase II Expanded Access Clinical TrialTargeted Therapy Technologies, LLC
- RECRUITINGEARLY PHASE1NCT06424301Targeting NUDT21 siRNA Drugs for Patients With Refractory RetinoblastomaEye & ENT Hospital of Fudan University
- RECRUITINGNCT06367530Trilateral Retinoblastoma: Incidence and OutcomesAmsterdam UMC, location VUmc
- ENROLLING BY INVITATIONNCT06227962Cognitive Functioning and Health Related Quality of Life in Retinoblastoma SurvivorsAmsterdam University Medical Center
- RECRUITINGPHASE2NCT05504291A Study to Give Treatment Inside the Eye to Treat RetinoblastomaChildren's Oncology Group
- RECRUITINGPHASE2, PHASE3NCT04681417Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual OutcomeInstitut Curie